What a busy week this one with the publishing of ANVISA’s Nitrosamine Guidance. I have received direct requests from some community members about facilitating a discussion with ANVISA and SINDUFARM on the guidance.
USP LATAM team already kick-off some of those activities, But I am especially interested in what are the questions that you would like us to bring forward? Does it make sense to organize an event to include industry experts presenting challenges and feedback?
1 Like
Hi Naiffer
Appreciate if an English translation is available of ANVISA"S guidance